Abstract:Objective To explore the effect of the Aidi Injection combined with chemotherapy scheme in the treatment of advanced colorectal cancer. Methods From June 2013 to June 2016, the clinical data of 70 patients with advanced colorectal cancer treated in Lu'an Hospital Affiliated to Anhui Medical University were retrospectively analyzed, patients were divided into control group and observation group according to the different methods of treatment, each group of 35 cases. The control group was treated by the standard chemotherapy of Oxaliplatin combined with Capecitabine, while the observation group was treated by Aidi Injection on the basis of the treatment of control group. The clinical efficacy of the two groups was compared; the quality of life was assessed before and after treatment by Karnofsky performance status (KPS) score, the improvement of quality of life after treatment was observed; the occurrence of adverse reactions of the two groups was compared. Results The effective rate of the observation group was higher than that of the control group (71.43% vs 60.00%), the difference was statistically significant (P < 0.05). After treatment, the improvement of KPS score in observation group was better than that of the control group, the difference was statistically significant (P < 0.05). The degree of white blood cells decline of the observation group was obviously lower than that of the control group (P < 0.05); the severity of platelet decline, gastrointestinal reaction, neurotoxicity were lighter than those of the control group, but there were no statistically significant differences between the two groups (P > 0.05). Conclusion The effect of Aidi Injection combined with chemotherapy scheme in the treatment of advanced colorectal cancer is significantly better than that of the pure chemotherapy, with less adverse reactions, which can obviously improve the quality of life, and it is worthy of clinical popularization and application.